• +353-1-415-1241(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
Royalty Financing Terms and Agreements in Pharma, Biotech and Diagnostics Product Image

Royalty Financing Terms and Agreements in Pharma, Biotech and Diagnostics

  • Published: December 2012
  • Region: Global
  • 263 Pages
  • CurrentPartnering

The Royalty Financing Terms and Agreements report provides comprehensive understanding and unprecedented access to the royalty financing agreements entered into by the worlds leading biopharma companies.

The report provides a detailed understand and analysis of how and why companies enter royalty financing partnering deals.

Understanding the flexibility of a prospective partner's negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered and rights transferred – contract documents provide this insight where press releases and databases do not.

This report contains links to online copies of actual royalty financing contract documents as submitted to the Securities Exchange Commission by biopharma companies and their partners.

Contract documents provide the answers to numerous questions about a prospective partner's flexibility on a wide range of important issues, many of which will have a significant impact on each READ MORE >

Executive Summary

Chapter 1 – Introduction

Chapter 2 – Trends in royalty financing dealmaking

2.1. Introduction
2.2. Difference between royalty and revenue financing
2.3. Trends in royalty financing deals since 2007
2.4. Reasons for entering into royalty financing partnering deals
2.5 The emergence of royalty asset purchase deals
2.4.1. Primary players in royalty asset purchase deals
2.4.2. Recent royalty asset purchase deals
2.4.3. The role of bigpharma in royalty buyback
2.4.4. The future of royalty asset purchase deals

Chapter 3 – Overview of royalty financing structure

3.1. Introduction
3.2. Anatomy of a royalty asset purchase agreement
3.3. Example royalty financing agreements
3.3.1. Case study 1: Emory University – Gilead Sciences – Royalty Pharma – July 2005
3.3.2. Case study 2: Enzon – Drug Royalty – August 2007
3.3.3. Case study 3: Royalty asset: DRI Capital – NPS Pharmaceuticals – July 2007
3.3.4. Case study 4: Royalty asset: TPG – CV Therapeutics – April 2008

Chapter 4 – Leading royalty financing deals

4.1. Introduction
4.2. Top royalty financing deals by value
4.3. Top revenue financing deals by value
4.4. Most active royalty financing dealmakers

Chapter 5 – Royalty financing contract documents 2007-2012

5.1. Introduction
5.2. Company A-Z

Chapter 6 – Royalty financing agreement directory 2007-2012

6.1. Introduction
6.2. Company A-Z
6.3. By therapy area

Appendices

Appendix 1 – Royalty financing references
Appendix 2 – Resources
Appendix 3 – Deal type definitions
Appendix 4 – Example royalty financing contract document
About Wildwood Ventures
Current Partnering
Current Agreements
Recent report titles from CurrentPartnering

Table of figures

Figure 1: Definition of royalty assets
Figure 2: Trends in royalty financing deal announcements, 2007-2012
Figure 3: Trends in revenue financing or ‘synthetic royalty' deal announcements, 2007-2012
Figure 4: Leading royalty asset investors
Figure 5: Recent royalty asset purchase agreements
Figure 6: Components of the royalty asset purchase deal structure
Figure 7: Top royalty financing deals by value since 2007
Figure 8: Top revenue financing deals by value since 2007
Figure 9: Most active royalty financing dealmakers 2007-2012
Figure 10: Online partnering resources
Figure 11: Deal type definitions
Figure 12: Royalty financing agreement for Qutenza – April 2010

The Royalty Financing Terms and Agreements in Pharma, Biotech and Diagnostics report provides detailed understanding and analysis of how and why companies enter royalty financing deals.

- Comprehensive directory of royalty financing deals since 2007
- Royalty financing contract documents
- Royalty financing agreement terms
- Royalty financing agreement structure
- Top royalty financing deals by value
- Most active Royalty financing dealmakers

Benefits:

Royalty Financing Terms and Agreements provides the reader with the following key benefits:

- In-depth understanding of royalty financing partnering deal trends since 2007
- Analysis of the structure of royalty financing partnering agreements with numerous real life case studies
- Comprehensive listing of all royalty financing deals since 2007, together with deal terms, value and press release
- Comprehensive access to actual royalty financing partnering contracts entered into by the world's biopharma companies
- Insight into the terms included in a royalty financing partnering agreement, together with real world clause examples
- Understand the key deal terms companies have agreed in previous deals
- Undertake due diligence to assess suitability of your proposed deal terms for partner companies

Note: Product cover images may vary from those shown

RELATED PRODUCTS